Anaptysbio, INC Form 4 insider transactions

NASDAQ
AnaptysBio's CFO, Dennis Mulroy, sold 1,500 shares of common stock at $23.72 per share on May 22, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
AnaptysBio CEO Daniel Faga sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).